These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28246390)

  • 1. PRL3 phosphatase active site is required for binding the putative magnesium transporter CNNM3.
    Zhang H; Kozlov G; Li X; Wu H; Gulerez I; Gehring K
    Sci Rep; 2017 Mar; 7(1):48. PubMed ID: 28246390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphocysteine in the PRL-CNNM pathway mediates magnesium homeostasis.
    Gulerez I; Funato Y; Wu H; Yang M; Kozlov G; Miki H; Gehring K
    EMBO Rep; 2016 Dec; 17(12):1890-1900. PubMed ID: 27856537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRL3 pseudophosphatase activity is necessary and sufficient to promote metastatic growth.
    Kozlov G; Funato Y; Chen YS; Zhang Z; Illes K; Miki H; Gehring K
    J Biol Chem; 2020 Aug; 295(33):11682-11692. PubMed ID: 32571875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of PRL-2·CNNM3 Protein Complex Formation Decreases Breast Cancer Proliferation and Tumor Growth.
    Kostantin E; Hardy S; Valinsky WC; Kompatscher A; de Baaij JH; Zolotarov Y; Landry M; Uetani N; Martínez-Cruz LA; Hoenderop JG; Shrier A; Tremblay ML
    J Biol Chem; 2016 May; 291(20):10716-25. PubMed ID: 26969161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A FRET-based screening method to detect potential inhibitors of the binding of CNNM3 to PRL2.
    Cai F; Huang Y; Wang M; Sun M; Zhao Y; Hattori M
    Sci Rep; 2020 Jul; 10(1):12879. PubMed ID: 32733084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protein tyrosine phosphatase PRL-2 interacts with the magnesium transporter CNNM3 to promote oncogenesis.
    Hardy S; Uetani N; Wong N; Kostantin E; Labbé DP; Bégin LR; Mes-Masson A; Miranda-Saavedra D; Tremblay ML
    Oncogene; 2015 Feb; 34(8):986-95. PubMed ID: 24632616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cyclic nucleotide-binding homology domain of the integral membrane protein CNNM mediates dimerization and is required for Mg
    Chen YS; Kozlov G; Fakih R; Funato Y; Miki H; Gehring K
    J Biol Chem; 2018 Dec; 293(52):19998-20007. PubMed ID: 30341174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Basis of the Oncogenic Interaction of Phosphatase PRL-1 with the Magnesium Transporter CNNM2.
    Giménez-Mascarell P; Oyenarte I; Hardy S; Breiderhoff T; Stuiver M; Kostantin E; Diercks T; Pey AL; Ereño-Orbea J; Martínez-Chantar ML; Khalaf-Nazzal R; Claverie-Martin F; Müller D; Tremblay ML; Martínez-Cruz LA
    J Biol Chem; 2017 Jan; 292(3):786-801. PubMed ID: 27899452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burst kinetics and CNNM binding are evolutionarily conserved properties of phosphatases of regenerating liver.
    Fakih R; Goldstein RH; Kozlov G; Gehring K
    J Biol Chem; 2023 Apr; 299(4):103055. PubMed ID: 36822330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The double lives of phosphatases of regenerating liver: A structural view of their catalytic and noncatalytic activities.
    Gehring K; Kozlov G; Yang M; Fakih R
    J Biol Chem; 2022 Jan; 298(1):101471. PubMed ID: 34890645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mg
    Chen YS; Kozlov G; Fakih R; Yang M; Zhang Z; Kovrigin EL; Gehring K
    Structure; 2020 Mar; 28(3):324-335.e4. PubMed ID: 31864811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRL-1/2 phosphatases control TRPM7 magnesium-dependent function to regulate cellular bioenergetics.
    Hardy S; Zolotarov Y; Coleman J; Roitman S; Khursheed H; Aubry I; Uetani N; Tremblay ML
    Proc Natl Acad Sci U S A; 2023 Apr; 120(14):e2221083120. PubMed ID: 36972446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatase of regenerating liver 3 (PRL3) provokes a tyrosine phosphoproteome to drive prometastatic signal transduction.
    Walls CD; Iliuk A; Bai Y; Wang M; Tao WA; Zhang ZY
    Mol Cell Proteomics; 2013 Dec; 12(12):3759-77. PubMed ID: 24030100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of the PRL phosphatases.
    Rios P; Li X; Köhn M
    FEBS J; 2013 Jan; 280(2):505-24. PubMed ID: 22413991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnesium-sensitive upstream ORF controls PRL phosphatase expression to mediate energy metabolism.
    Hardy S; Kostantin E; Wang SJ; Hristova T; Galicia-Vázquez G; Baranov PV; Pelletier J; Tremblay ML
    Proc Natl Acad Sci U S A; 2019 Feb; 116(8):2925-2934. PubMed ID: 30718434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphatase and Pseudo-Phosphatase Functions of Phosphatase of Regenerating Liver 3 (PRL-3) Are Insensitive to Divalent Metals In Vitro.
    Jolly JT; Cheatham TC; Blackburn JS
    ACS Omega; 2023 Aug; 8(33):30578-30589. PubMed ID: 37636930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metastasis-promoting phosphatase PRL-3 shows activity toward phosphoinositides.
    McParland V; Varsano G; Li X; Thornton J; Baby J; Aravind A; Meyer C; Pavic K; Rios P; Köhn M
    Biochemistry; 2011 Sep; 50(35):7579-90. PubMed ID: 21806020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localizing PRL-2 expression and determining the effects of dietary Mg(2+) on expression levels.
    Gungabeesoon J; Tremblay ML; Uetani N
    Histochem Cell Biol; 2016 Jul; 146(1):99-111. PubMed ID: 27015884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular function and biological importance of CNNM family Mg2+ transporters.
    Funato Y; Miki H
    J Biochem; 2019 Mar; 165(3):219-225. PubMed ID: 30476181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNAi‑mediated knockdown of PRL‑3 inhibits cell invasion and downregulates ERK 1/2 expression in the human gastric cancer cell line, SGC‑7901.
    Cao Y; Tu Y; Mei J; Li Z; Jie Z; Xu S; Xu L; Wang S; Xiong Y
    Mol Med Rep; 2013 Jun; 7(6):1805-11. PubMed ID: 23589069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.